Loading clinical trials...
Loading clinical trials...
The objective of this study was to compare the safety and efficacy of 0.25% HL036 Ophthalmic Solutions to placebo for the treatment of the signs and symptoms of dry eye.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
HanAll BioPharma Co., Ltd.
Collaborators
NCT07463950 · Dry Eye Disease (DED)
NCT07412860 · Dry Eye Syndromes, Dry Eye Disease (DED)
NCT07363824 · Dry Eye Disease, Iron
NCT07396441 · Juvenile Open Angle Glaucoma, Dry Eye Disease (DED), and more
NCT05865457 · Dry Eye Disease
Cornea and Cataract Consultants of Arizona
Phoenix, Arizona
Eye Research Foundation
Newport Beach, California
East West Eye Institute
Torrance, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions